表紙
市場調查報告書

傷口負壓治療 (NPWT) :開發中產品分析

Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 333943
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
傷口負壓治療 (NPWT) :開發中產品分析 Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年07月01日內容資訊: 英文 73 Pages
簡介

本報告提供現在正在開發中的傷口負壓治療 (NPWT) 之開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 傷口負壓治療 (NPWT) 概要

第3章 開發中的產品

  • NPWT - 開發中產品:各開發階段
  • NPWT - 開發中產品:各地區
  • NPWT - 開發中產品:各法律途徑
  • NPWT - 開發中產品:各核准時期 (預定)

第4章 傷口負壓治療 (NPWT) :正在開發的開發中產品 (各企業)

  • NPWT企業 - 開發中產品:各開發階段
  • NPWT - 開發中產品:各開發階段

第5章 傷口負壓治療 (NPWT) 企業與產品概要

第6章 傷口負壓治療 (NPWT) :最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0613EPD

GlobalData's Medical Devices sector report, "Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2018" provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Negative Pressure Wound Therapy (NPWT) Overview 5

3 Products under Development 6

  • 3.1 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 6
  • 3.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 7
  • 3.3 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 8
  • 3.4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 9

4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products under Development by Companies 10

  • 4.1 Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development 10
  • 4.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 11

5 Negative Pressure Wound Therapy (NPWT) Companies and Product Overview 12

  • 5.1 Acelity L.P. Inc. Company Overview 12
    • 5.1.1 Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
  • 5.2 Adept Medical Ltd Company Overview 14
    • 5.2.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.3 Applied Tissue Technologies LLC Company Overview 15
    • 5.3.1 Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.4 Invacare Corporation Company Overview 16
    • 5.4.1 Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.5 MLM Biologics Inc Company Overview 17
    • 5.5.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.6 Montana State University Company Overview 18
    • 5.6.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.7 Otivio AS Company Overview 19
    • 5.7.1 Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.8 Shieldheart Medtech AB Company Overview 20
    • 5.8.1 Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.9 Smith & Nephew Plc Company Overview 21
    • 5.9.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.10 University of Pisa Company Overview 22
    • 5.10.1 University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.11 Wake Forest Baptist Medical Center Company Overview 23
    • 5.11.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.12 Worldwide Innovative Healthcare, Inc. Company Overview 24
    • 5.12.1 Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

6 Negative Pressure Wound Therapy (NPWT) - Recent Developments 25

  • 6.1 May 17, 2018: NanoVibronix Provides Business Update for the First Quarter 2018 25
  • 6.2 May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer 25
  • 6.3 May 08, 2018: Smith & Nephew: Change of Directorate 25
  • 6.4 May 07, 2018: Invacare Reports Results for First Quarter 2018 26
  • 6.5 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report 27
  • 6.6 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018 29
  • 6.7 May 01, 2018: One Call Partners with Acelity to Improve Patient Adherence to Advanced Wound Therapy 30
  • 6.8 Apr 25, 2018: New Meta-analysis Demonstrates the Effectiveness of PICO NPWT in Helping to Prevent Surgical Site Complications versus Standard Care 31
  • 6.9 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew 31
  • 6.10 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K 33
  • 6.11 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth 34
  • 6.12 Mar 01, 2018: Smith & Nephew: Change in Directorate 34
  • 6.13 Feb 22, 2018: Invacare Appoints Kathleen Leneghan Chief Financial Officer 34
  • 6.14 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results 35
  • 6.15 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018 36
  • 6.16 Feb 07, 2018: Smith & Nephew announces European launch of new PICO 7 Single Use Negative Pressure Wound Therapy System 37
  • 6.17 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors 38
  • 6.18 Feb 07, 2018: Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017 38
  • 6.19 Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% 41
  • 6.20 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director 42
  • 6.21 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director 43
  • 6.22 Jan 25, 2018: Lohmann & Rauscher: Personnel Change in Executive Board of L&R 43
  • 6.23 Dec 21, 2017: NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders 44
  • 6.24 Dec 07, 2017: Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment 46
  • 6.25 Nov 27, 2017: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications 47
  • 6.26 Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million 48
  • 6.27 Nov 07, 2017: Invacare Reports Results for Third Quarter 2017 49
  • 6.28 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018 51
  • 6.29 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan 52
  • 6.30 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report 55
  • 6.31 Nov 02, 2017: Invacare Announces Departure of Chief Financial Officer 56
  • 6.32 Oct 25, 2017: New microbiology laboratory enables effective development of antimicrobial wound dressings 56
  • 6.33 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer's intention to retire by end of 2018 58
  • 6.34 Oct 09, 2017: Notice of Chief Executive Officer's intention to retire by end of 2018 58
  • 6.35 Oct 02, 2017: Smith & Nephew Announces Directorate Change 59
  • 6.36 Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca's BioVentureHub 59
  • 6.37 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors 59
  • 6.38 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 59
  • 6.39 Aug 21, 2017: PREVENA Incision Management System Shown to Reduce Incisional Pain and Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery 60
  • 6.40 Aug 21, 2017: Invacare Appoints Barbara Bodem to Board of Directors 61
  • 6.41 Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 61
  • 6.42 Aug 07, 2017: Invacare Reports Results for Second Quarter 2017 62
  • 6.43 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 64
  • 6.44 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 65
  • 6.45 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 69
  • 6.46 Jun 26, 2017: Invacare Announces Closure of China Manufacturing Facility in Line with Strategic Transformation 69

7 Appendix 70

  • 7.1 Methodology 70
  • 7.2 About GlobalData 73
  • 7.3 Contact Us 73
  • 7.4 Disclaimer 73

1.1 List of Tables

  • Table 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 6
  • Table 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 7
  • Table 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 8
  • Table 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 9
  • Table 5: Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development 10
  • Table 6: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 11
  • Table 7: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
  • Table 8: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Status 12
  • Table 9: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Description 13
  • Table 10: Negative Pressure Regenerative Medicine - Hard Tissue - Product Status 13
  • Table 11: Negative Pressure Regenerative Medicine - Hard Tissue - Product Description 13
  • Table 12: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 13: Wound Pressure Device - Product Status 14
  • Table 14: Wound Pressure Device - Product Description 14
  • Table 15: Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 16: Next Generation Negative Pressure Wound Therapy Device - Product Status 15
  • Table 17: Next Generation Negative Pressure Wound Therapy Device - Product Description 15
  • Table 18: Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 19: Negative-Pressure Wound Therapy System - Product Status 16
  • Table 20: Negative-Pressure Wound Therapy System - Product Description 16
  • Table 21: MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 22: Wound Matrix - Negative Pressure Wound Therapy - Product Status 17
  • Table 23: Wound Matrix - Negative Pressure Wound Therapy - Product Description 17
  • Table 24: Montana State University Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 25: Tissue Cooling Negative Pressure Wound Therapy System - Product Status 18
  • Table 26: Tissue Cooling Negative Pressure Wound Therapy System - Product Description 18
  • Table 27: Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 28: FlowOx - Next Version - Product Status 19
  • Table 29: FlowOx - Next Version - Product Description 19
  • Table 30: Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 31: ShieldHeart Protection Device - Product Status 20
  • Table 32: ShieldHeart Protection Device - Product Description 20
  • Table 33: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 34: RENASYS TOUCH Connect - Product Status 21
  • Table 35: RENASYS TOUCH Connect - Product Description 21
  • Table 36: University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 37: Smart Wearable And Autonomous Negative Pressure Device - Product Status 22
  • Table 38: Smart Wearable And Autonomous Negative Pressure Device - Product Description 22
  • Table 39: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 40: Mechanical Tissue Resuscitation Device - Product Status 23
  • Table 41: Mechanical Tissue Resuscitation Device - Product Description 23
  • Table 42: Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 43: Wound-Pump - Product Status 24
  • Table 44: Wound-Pump - Product Description 24
  • Table 45: Glossary 72

1.2 List of Figures

  • Figure 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 6
  • Figure 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 7
  • Figure 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 8
  • Figure 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 9